Methods for assessing, improving, or maintaining urogenital health in postmenopausal women
CA 2541348 A1 · Owner: Thompson, David Duane · Inventors: Lee, Andrew George; Thompson, David Duane; Day, Wesley Warren
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to methods and kits useful for improving or maintaining urogenital health using an estrogen agonist/antagonist. The methods of treatment are effective for improving or maintaining urogenital health while substantially reducing the concomitant liability of adverse effects associated with estrogen administration. This invention also relates to methods of assessing vaginal health. Preferred estrogen agonists/antagonists are of the formula (I):, (see figure I), wherein A is CH2 or NR; B D and E are CH or N; Y is an, optionally substituted carbocyclic or heterocyclic group; Z1 is a hydrocarbon spacer optionally interrupted by a heteroatom; G is an amine group; R is H or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 12, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 12, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 12, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.